Orchid Cellmark Awarded FBI Contracts

Orchid Cellmark Awarded FBI Contracts to Develop SNP Technology for Advanced Forensic Applications
Tue 7:58am

Die geht heute durch die Decke. Schätze mal 50%

CIAO

The informative Y-SNP panel could also potentially be used as a screening tool to derive broad physical characteristics based on information about a suspect's ancestral origin. These physical characteristics could be useful in so-called "no-suspect" crimes where investigators have DNA evidence but no other clues to identify possible perpetrators. Following the development of the Y-SNP panel, Orchid believes it would be the first private forensic lab to offer a gender-specific SNP-based panel as part of its services.

The second contract is to develop an expanded panel of robust SNP markers that will nearly double the number of SNPs Orchid currently uses, thereby potentially increasing its ability to identify individuals using degraded DNA. Titled "High-throughput Autosomal SNP Typing for Human Identification," this effort will build on the assay Orchid previously developed to help identify World Trade Center victims.

"Orchid's pioneering SNP analysis technology has a number of important applications to improve human identity profiling, so it is fitting that Orchid Cellmark was selected to develop these new tests by the FBI, the nation's top crime-fighting institution," said Mark D. Stolorow, executive director of Orchid Cellmark. "As a leading innovator in forensic genetic testing for nearly two decades, we look forward to further building on Orchid's proprietary SNP technology to expand our service offerings in order to better serve our law enforcement clients."

Orchid Cellmark has a long history of using advanced DNA analysis techniques for identity testing. It was among the first laboratories to use new DNA technology to identify casualties in the 1991 Persian Gulf War. Orchid's pioneering SNP technology is currently being used in collaboration with the New York Office of Medical Examiner in an attempt to identify the large number of 9/11 World Trade Center victims for whom conventional identification methods have failed.

The FBI is the investigative arm of the U.S. Department of Justice. The mission of the FBI is to protect and defend the U.S. against terrorist and foreign intelligence threats, to uphold and enforce the criminal laws of the U.S., and to provide leadership and criminal justice services to federal, state, municipal and international agencies and partners. More information on the FBI can be found at www.fbi.gov.

CIAO

       
     


Hier liegt das Geld auf der Strasse.
Ist nur meine Meinung.

CIAO

ja gar nicht voll dieses Jahr. Tolle Shares, tolle Performance Deinerseits.
AKAM, TMTA, weiss nicht mehr alle genau. Aber wenn jemand über US-Titel schreibt, lese ich meistens rein.
Hattest Du keine Lust auf US-Club?
Du machst Dein Ding alleine sehr gut, weiss ich doch. Aber noch nen Experten können wir immer gebrauchen.
So, muss jetzt mal kurz zum Arzt, deshalb bin ich jetzt weg.

Gruss E.

Danke für deine Worte ,es ist wie Balsam........
Ich verstehe hier einige nicht,die z.B in WCM einsteigen wie die Blöden,verbilligen 6 mal und reden die Aktie noch schön.
Ich meinerseits , habe die Leute immer davor gewarnt, aber was solls.
ORCHID-BIO wird der nächste Renner.
Mein KZ 4$ bis März 2004 !!

CIAO

Volumen in den USA haben gestern schon angezogen - und bin mal gespannt was heute kommt !!

Brief steht bei 1,33 !!


Gruß

leo

aber nicht mehr lange !!

Gruß

leo

Two major contracts in one week

Long-Term Sentiment: Strong Buy  12/03/03


Product perfection funding from FBI and Los Angeles PD. How much confirmation of industry leadership does the market want before we move on up to $2.

CIAO

das ist eine richtig gute long Aktie !!

Wir werden noch viel Spaß haben .

Gruß

leo

quotes.barchart.com/texpert.asp?sym=ORCH

View: Quarterly Data | Annual DataAll numbers in thousandsPERIOD ENDING30-Sep-0330-Jun-0331-Mar-0331-Dec-02Total Revenue11,833  12,364  12,738  1,173  Cost of Revenue7,713  6,653  6,997  288  Gross Profit4,120  5,711  5,741  885  Operating ExpensesResearch Development642  1,159  1,205  2,566  Selling General and Administrative6,755  8,157  7,828  5,732  Non Recurring(72)754  -  17,381  Others452  453  455  123  Total Operating Expenses7,777  10,523  -  25,802  Operating Income or Loss(3,657)(4,812)(3,747)(24,917)Income from Continuing OperationsTotal Other Income/Expenses Net1,507  187  166  (924)Earnings Before Interest And Taxes(2,150)(4,625)(3,581)(25,841)Interest Expense114  144  156  (80)Income Before Tax(2,264)(4,769)(3,737)(25,761)Income Tax Expense549  716  344  317  Minority Interest-  -  -  -  Net Income From Continuing Ops(2,813)(5,485)(4,081)(26,078)Non-recurring EventsDiscontinued Operations(1,028)(3,983)(199)(9,003)Extraordinary Items-  -  -  -  Effect Of Accounting Changes-  -  -  -  Other Items-  -  -  -  Net Income(3,841)(9,468)(4,280)(35,081)Preferred Stock And Other Adjustments(1,153)(715)(744)-  Net Income Applicable To Common Shares($4,994)($10,183)($5,024)($35,081View: Quarterly Data | Annual DataAll numbers in thousandsPERIOD ENDING31-Dec-0231-Dec-0131-Dec-00Total Revenue50,425  31,215  18,381  Cost of Revenue27,647  18,689  10,888  Gross Profit22,778  12,526  7,493  Operating ExpensesResearch Development21,006  33,550  28,881  Selling General and Administrative41,668  34,725  29,970  Non Recurring27,651  31,040  -  Others3,039  -  -  Total Operating Expenses93,364  -  -  Operating Income or Loss(70,586)(86,789)(51,358)Income from Continuing OperationsTotal Other Income/Expenses Net(502)2,958  3,988  Earnings Before Interest And Taxes(71,088)(83,831)(47,370)Interest Expense583  847  497  Income Before Tax(71,671)(84,678)(47,867)Income Tax Expense(577)-  -  Minority Interest-  -  -  Net Income From Continuing Ops(71,094)(84,678)(47,867)Non-recurring EventsDiscontinued Operations(9,003)-  -  Extraordinary Items-  -  -  Effect Of Accounting Changes-  -  -  Other Items-  -  -  Net Income(80,097)(84,678)(47,867)Preferred Stock And Other Adjustments-  -  (29,574)Net Income Applicable To Common Shares($80,097)($84,678)($77,441

View: Quarterly Data | Annual Data

All numbers in thousands

PERIOD ENDING 30-Sep-03 30-Jun-03 31-Mar-03 31-Dec-02 Total Revenue 11,833   12,364   12,738   1,173   Cost of Revenue 7,713   6,653   6,997   288   Gross Profit 4,120   5,711   5,741   885   Operating Expenses Research Development 642   1,159   1,205   2,566   Selling General and Administrative 6,755   8,157   7,828   5,732   Non Recurring (72) 754   -   17,381   Others 452   453   455   123   Total Operating Expenses 7,777   10,523   -   25,802   Operating Income or Loss (3,657) (4,812) (3,747) (24,917) Income from Continuing Operations Total Other Income/Expenses Net 1,507   187   166   (924) Earnings Before Interest And Taxes (2,150) (4,625) (3,581) (25,841) Interest Expense 114   144   156   (80) Income Before Tax (2,264) (4,769) (3,737) (25,761) Income Tax Expense 549   716   344   317   Minority Interest -   -   -   -   Net Income From Continuing Ops (2,813) (5,485) (4,081) (26,078) Non-recurring Events Discontinued Operations (1,028) (3,983) (199) (9,003) Extraordinary Items -   -   -   -   Effect Of Accounting Changes -   -   -   -   Other Items -   -   -   -   Net Income (3,841) (9,468) (4,280) (35,081) Preferred Stock And Other Adjustments (1,153) (715) (744) -   Net Income Applicable To Common Shares ($4,994) ($10,183) ($5,024) ($35,081

 

 

View: Quarterly Data | Annual Data

All numbers in thousands

PERIOD ENDING 31-Dec-02 31-Dec-01 31-Dec-00 Total Revenue 50,425   31,215   18,381   Cost of Revenue 27,647   18,689   10,888   Gross Profit 22,778   12,526   7,493   Operating Expenses Research Development 21,006   33,550   28,881   Selling General and Administrative 41,668   34,725   29,970   Non Recurring 27,651   31,040   -   Others 3,039   -   -   Total Operating Expenses 93,364   -   -   Operating Income or Loss (70,586) (86,789) (51,358) Income from Continuing Operations Total Other Income/Expenses Net (502) 2,958   3,988   Earnings Before Interest And Taxes (71,088) (83,831) (47,370) Interest Expense 583   847   497   Income Before Tax (71,671) (84,678) (47,867) Income Tax Expense (577) -   -   Minority Interest -   -   -   Net Income From Continuing Ops (71,094) (84,678) (47,867) Non-recurring Events Discontinued Operations (9,003) -   -   Extraordinary Items -   -   -   Effect Of Accounting Changes -   -   -   Other Items -   -   -   Net Income (80,097) (84,678) (47,867) Preferred Stock And Other Adjustments -   -   (29,574) Net Income Applicable To Common Shares ($80,097) ($84,678) ($77,441

die steht bei 1,34 $ = 1,15 Euro !! und läuft heute Abend noch auf 1,36 $

in München noch für 1,11 Euro zu haben - aber macht selber was draus !!

Gruß

leo

He said that the decision to reopen the case had been taken only after consultation with PC Blakelock's family.

"We accept that the decision to launch this fresh investigation will be difficult for some sections of the community," he said.

"MPS officers have consulted with a wide range of people in reaching this decision to reopen the case.

"We are grateful for the input we have received, particularly from Keith's family, the local community and the wider black community, whose views have greatly shaped how we will approach this new inquiry."

PC Blakelock, who left three sons, was set upon by a mob and hacked to death during the riots on October 6, 1985. The riots were sparked by the death of 49-year-old Cynthia Jarrett during a police raid. She died of heart failure after four police officers burst into her home.

Winston Silcott, Mark Braithwaite and Engin Raghip were all originally found guilty of PC Blakelock's murder, but the Court of Appeal overturned their convictions in 1991.

Less than two months ago, PC Blakelock's widow said that she still believed his killer would be brought to justice.

Elizabeth Johnson, 52, who now lives in Boldon Colliery, on the outskirts of Sunderland, Tyne and Wear, has since remarried.

She spoke after it emerged that Mr Silcott was to be freed from jail.

Mrs Johnson said at the time: "If the man is going to be let out of prison then nothing I can do will change that. But I do believe that guilty people will be brought to justice and we will see people being punished for what they did to Keith.

"They have deprived a family of a father and a grandfather. It never leaves you and it never goes away, you just get better at handling the situation. People cannot get away with murdering people and I believe that life should mean life. If they don't get what they deserve in this life they will in another."



CIAO

Wednesday, 3 December, 2003, 07:20 GMT  

DNA tests used in 1982 murder hunt


Miss Yianni was seen talking to a young man on her doorstep
Detectives are using new DNA forensic techniques to try to solve a murder in north London 21 years ago.
Yiannoulla Yianni, 17, was strangled and sexually assaulted at her home in Belsize Road, Hampstead in August 1982.

More than 1,000 people gave statements at the time and police now want all of them to come forward again.

They are offering a £10,000 reward for information which helps them convict Miss Yianni's killer, whom detectives believe she knew.

Postmen are delivering 5,000 leaflets to homes in and around Hampstead as part of the appeal.

Police say newly-developed forensic techniques have opened up new lines of inquiry and they are trying to trace everyone who gave statements or fingerprints at the time.

  There must be people out there who know what happened

Detective Chief Inspector Richard Freeman  
Detective Chief Inspector Richard Freeman said: "New advances in DNA techniques mean now we really can solve this case, but need the public to come forward and offer their help.

"This family have had to live with this tragic loss for over 21 years.

"There must be people out there who know what happened on that day and were reluctant to speak to police at the time.

"But 21 years on, whatever held them back may no longer apply."

Miss Yianni, who was Greek-Cypriot, spent the morning of 13 August 1982 at home with her mother.

They walked to the family shop in Fairhazel Road at 1230 BST and Miss Yianni went home alone to prepare dinner.

Her parents found her body when they returned home at 1500 BST.

Miss Yianni was seen talking to a man in his 20s, who was possibly Greek or Cypriot, on the doorstep of her home and police are still trying to find him.

They also want to hear from any of her friends from Quintin Kynaston School and colleagues from Woolworths in Finchley Road, both in St John's Wood.

They also want anyone who attended Greek dancing classes at 94 Camden Road, Camden, to come forward.

 

CIAO

P.S Ich pushe nicht.
Diese Aktie hat echt enormes Potential.

CIAO

es werden jeden Tag mehr - die wird auch heute wieder steigen , sowohl vom Volumen als auch vom Preis !

Gruß

leo

Thursday, December 4, 2003 IPO Central Hoover's Books Home About Hoover's Subscription Options Help Log In Orchid BioSciences, Inc. (NASDAQ: ORCH)
4390 U.S. Route One
Princeton, NJ 08540 (Map)
Phone: 609-750-2200
Fax: 609-750-6400

www.orchid.com


ValuEngine Assessment
Today's Fair Value  5.32
Assessment ORCH is 75.00% undervalued.

Click here  to purchase a Detailed Research Report for Orchid Biosciences Inc from VEReports.com


Ticker Information
Last Trade 1.33
Change 0.00
Volume 0
Industry  BIOTECHNOLOGY
Sector  Health Care

Available research reports on Orchid Biosciences Inc
ValuEngine Quantitative Valuation Report: Forecasts, market valuations, comparables, quantitative summary and financials. Based on proprietary Academic Valuation models.    
ValuEngine Summary Report: Quantitative data, forecast report. Based on Academic Valuation models.  
OptionSmart Technical Analysis Report: Comprehensive multi-level analysis, including sector/industry/sub-industry perspective. Daily and weekly technical charts flagged with trading signals. Based on real predictive accuracy of technical indicators.  
Sector Data Company Profile Report: The Company Profile Report includes the following: * Overview of how the Company products/services map in the Hierarchy * Business Description * Chart * Company Highlights * Products/Services - detailed categorization with tradenames * Key Financials/Ratios * Major Competitors defined by Company * Major Customers defined by Company * Strategic Partners defined by Company * Revenue by Geography * Revenue by Operating Division    
ValuEngine Comprehensive Stock Rating Report: Lists more than 4000 ValuEngine Ratings on stocks from 5-engine to 1-engine companies. Engine Ratings, 1 month forecast and fair market valuation. Sorted by ValuEngine 1-5 rating. Also available in Excel or CSV formats upon request.    

  how to use this page
about our models
benchmark portfolios
advanced screening
portfolio
Related Products From Our Trusted Partners
Buy Reports and Books
D&B Business/Credit Reports: Orchid BioSciences, Inc.

(D&B, Sep 1, 2003, Business Reports)
Biotech Watch Report: Orchid BioSciences

(Biotech Watch LLC., Oct 1, 2003, Business Reports)
eBusiness Trademark Reports: Orchid BioSciences, Inc.

(TrademarkBots.com, Inc., Sep 1, 2003, Business Reports)
Orchid BioSciences, Inc.: Company Profile

(Datamonitor, Oct 1, 2003, Business Reports)
Quantitative Report for ORCH

(ValuEngine, Inc., Sep 1, 2003, Business Reports)
Diagnostic Substances Mfg Deluxe Set

(Harris InfoSource, Aug 12, 2003, Business Reports)
Biotechnology Research Equipment: Financial Analysis Profiles

(BizMiner, May 21, 2003, Business Reports)
Medical and Diagnostic Laboratories in the US

(IBISWorld, Apr 28, 2003, Business Reports)

More Reports and Books »
Report Search
  

Additional 3rd Party Libraries
Build Lead Lists
Use Hoover's Lead Finder to create prospect and contact lists.

Additional Research On Orchid BioSciences
Corporate Hierarchy  


Featured Research
TrademarkBots

For real-time, eBusiness Competitive Intelligence on brands, trademarks and executives, order your eBusiness Trademark Report today.


Harris InfoSource
Generate prospect lists, identify lucrative sales leads, and analyze your markets accurately.  Harris InfoSource offers 750,000 US company profiles featuring 35 fields of vital information.

Indicates subscriber-only content..



Copyright© 2003, Hoover's, Inc.

 

Ich bin bereit...........

 

CIAO

dann haben wir aber was schönes im Depot !

Gruß

leo